secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0001213900-25-063277
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics sets 2025 annual meeting for Sep 3; proposal deadline Jul 21
--------------------------------------------------------------------------------

- Annual meeting set for September 3, 2025; proxy materials expected available July 24, 2025.
- Stockholder proposals under Rule 14a-8 must be received by July 21, 2025.
- Universal proxy rule notice for director nominations also due by July 21, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025063277/0001213900-25-063277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025063277/ea0248679-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-063277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer